MARKET

EBS

EBS

Emergent Biosolutions Inc
NYSE
6.93
-0.35
-4.81%
After Hours: 6.94 +0.01 +0.14% 19:34 07/18 EDT
OPEN
7.33
PREV CLOSE
7.28
HIGH
7.43
LOW
6.91
VOLUME
677.11K
TURNOVER
--
52 WEEK HIGH
15.10
52 WEEK LOW
4.020
MARKET CAP
376.15M
P/E (TTM)
-2.5589
1D
5D
1M
3M
1Y
5Y
1D
Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025
Barchart · 4d ago
Weekly Report: what happened at EBS last week (0707-0711)?
Weekly Report · 5d ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 07/09 11:30
Emergent BioSolutions: Strategic Positioning and Achievements Drive Buy Rating
TipRanks · 07/09 10:16
Emergent BioSolutions signs contract modification award for CNJ-016
Seeking Alpha · 07/08 21:25
Emergent BioSolutions Shares Rise Over 6% After HHS Contract Modification
Dow Jones · 07/08 21:13
Emergent Biosolutions secures $51.9M contract modification award for smallpox preparedness
Seeking Alpha · 07/08 21:12
Emergent BioSolutions secures $51.9M contract modification
TipRanks · 07/08 20:50
More
About EBS
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.

Webull offers Emergent Biosolutions Inc stock information, including NYSE: EBS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EBS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EBS stock methods without spending real money on the virtual paper trading platform.